369 related articles for article (PubMed ID: 18516027)
41. Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy.
Miyata H; Yoshioka A; Yamasaki M; Nushijima Y; Takiguchi S; Fujiwara Y; Nishida T; Mano M; Mori M; Doki Y
Cancer; 2009 Jul; 115(14):3324-34. PubMed ID: 19452547
[TBL] [Abstract][Full Text] [Related]
42. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
43. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
[No Abstract] [Full Text] [Related]
44. Effect of chemoradiotherapy for neural invasion in an advanced esophageal cancer.
Tanaka A; Ishikawa S; Okuno K; Shiozaki H
Hepatogastroenterology; 2008; 55(84):963-6. PubMed ID: 18705308
[TBL] [Abstract][Full Text] [Related]
45. Treatment of locally advanced esophageal cancer with surgery and chemoradiation.
Siersema PD; van Hillegersberg R
Curr Opin Gastroenterol; 2008 Jul; 24(4):535-40. PubMed ID: 18622172
[TBL] [Abstract][Full Text] [Related]
46. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
47. Chemoradiotherapy for esophageal cancer: current status and perspectives.
Ohtsu A
Int J Clin Oncol; 2004 Dec; 9(6):444-50. PubMed ID: 15616874
[TBL] [Abstract][Full Text] [Related]
48. Combined-modality therapy for gastric cancer.
Yao JC; Mansfield PF; Pisters PW; Feig BW; Janjan NA; Crane C; Ajani JA
Semin Surg Oncol; 2003; 21(4):223-7. PubMed ID: 14648779
[TBL] [Abstract][Full Text] [Related]
49. Overall survival with cisplatin and 5-fluorouracil neoadjuvant treatment in patients with esophageal cancer: single-center experience.
Idelevich E; Buyevich V; Machlenkin S; Ziv-Sokolovsky N; Dinerman M; Brenner B; Kashtan H
Onkologie; 2008 Dec; 31(12):673-7. PubMed ID: 19060505
[TBL] [Abstract][Full Text] [Related]
50. Complete clinical response after preoperative chemoradiation in rectal cancer: is a "wait and see" policy justified?
Glynne-Jones R; Wallace M; Livingstone JI; Meyrick-Thomas J
Dis Colon Rectum; 2008 Jan; 51(1):10-9; discussion 19-20. PubMed ID: 18043968
[TBL] [Abstract][Full Text] [Related]
51. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response.
Sims-Mourtada J; Izzo JG; Apisarnthanarax S; Wu TT; Malhotra U; Luthra R; Liao Z; Komaki R; van der Kogel A; Ajani J; Chao KS
Clin Cancer Res; 2006 Nov; 12(21):6565-72. PubMed ID: 17085672
[TBL] [Abstract][Full Text] [Related]
52. The role of chemotherapy in the treatment of esophageal cancer.
Kelsen DP
Chest Surg Clin N Am; 1994 Feb; 4(1):173-84. PubMed ID: 8055280
[TBL] [Abstract][Full Text] [Related]
53. Neoadjuvant chemotherapy versus surgery alone for locally advanced gastric cancer: a retrospective comparative study.
Wang LB; Shen JG; Xu CY; Chen WJ; Song XY; Yuan XM
Hepatogastroenterology; 2008; 55(86-87):1895-8. PubMed ID: 19102417
[TBL] [Abstract][Full Text] [Related]
54. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of oesophageal cancer.
Veuillez V; Rougier P; Seitz JF
Best Pract Res Clin Gastroenterol; 2007; 21(6):947-63. PubMed ID: 18070697
[TBL] [Abstract][Full Text] [Related]
55. New options in the treatment of locally advanced head and neck cancer: role for induction chemotherapy.
Cruz JJ; Ocaña A; Navarro M; Barco ED; Fonseca E
Cancer Treat Rev; 2008 May; 34(3):268-74. PubMed ID: 18194842
[TBL] [Abstract][Full Text] [Related]
56. Neoadjuvant therapy for gastrointestinal cancers.
Kelsen D
Oncology (Williston Park); 1993 Sep; 7(9):25-32; discussion 32, 35-6, 41. PubMed ID: 8217529
[TBL] [Abstract][Full Text] [Related]
57. [Phase III clinical trial for esophageal cancer using radiotherapy].
Ogino T
Gan To Kagaku Ryoho; 1995 Feb; 22(3):341-9. PubMed ID: 7533489
[TBL] [Abstract][Full Text] [Related]
58. Neoadjuvant therapy for oesophagogastric cancer.
Lordick F; Stein HJ; Peschel C; Siewert JR
Br J Surg; 2004 May; 91(5):540-51. PubMed ID: 15122603
[TBL] [Abstract][Full Text] [Related]
59. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
60. Neoadjuvant radiochemotherapy for rectal cancer.
Vini L
Dig Dis; 2007; 25(1):56-66. PubMed ID: 17384509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
